News
AMT-130 is administered through magnetic resonance imaging-guided, convection-enhanced stereotactic neurosurgical delivery into the striatum.
3d
Pharmaceutical Technology on MSNFDA grants breakthrough status to uniQure’s Huntington’s disease therapyThe US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for treating ...
Qure's long-term success hinges on overcoming regulatory and logistical challenges. See why I rate QURE stock a hold.
Northern Scotland has one of the highest rates of Huntington’s disease in the world, a study has found. The number of people ...
A major health alert has been issued for anyone who has visited a major city in the last 10 days after several cases of a potentially life-threatening disease were confirmed. Over the past three ...
Parkinson’s disease is a chronic neurological disorder that mainly affects movement, but it can also impact speech, mood, sleep, and even memory. While medications help manage symptoms ...
Huntington Place hosted the largest and most influential industrial 3D printing event on Wednesday. Projections show the industry could reach $16 billion by the end of 2025. DETROIT (FOX 2 ...
Pridopidine showed promise in patients with Huntington’s disease who were not on antidopaminergic medications. The safety and tolerability of pridopidine was comparable to placebo. SAN DIEGO ...
Editor’s note: CNN Chief Medical Correspondent Dr. Sanjay Gupta and writer Sandee LaMotte are part of the study covered in this story and have written about their experiences. When Penny Ashford ...
Filmmaker Tahira Kashyap has revealed that her breast cancer has relapsed, seven years after her initial diagnosis in 2018. In a heartfelt post on Instagram, she wrote, “Seven-year itch or the power ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results